3.0
31 Oct 2015
Anonymous employee
Former employee
Recommend
CEO approval
Business outlook
Pros
Professional satisfaction from work responsibilities
Cons
Pearson has been plagued of late by loss of mega contracts, dramatic drop in share value, shedding of major assets, virtual information overload, and a business model that even MBAs cannot understand. What a new board chairman from Big Pharma can add, will remain to be seen. The onslaught of negative press in business media and respected major newspapers has resulted in plummeting credibility. What do I recommend? Bring in an outside third party of management consultants, such as McKinsey, to provide a complete evaluation and assessment of the company as a whole.